National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk-Reference-Cited by-同舟云学术

National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk

Published:2019-11 Issue:6 Volume:13 Page:860-872
ISSN:1933-2874
Container-title:Journal of Clinical Lipidology
language:en
Short-container-title:Journal of Clinical Lipidology

Author:

Orringer Carl E.,Jacobson Terry A.,Maki Kevin C.

Funder

Acasti

Akcea

Amgen

Corvidia

Matinas BioPharma

Pharmavite

Regeneron

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference70 articles.

1. Omega-3 polyunsaturated fatty acid biomarkers and coronary heart disease: pooling project of 19 cohort studies;Del Gobbo;JAMA Intern Med,2016

2. Marine (n-3) fatty acids, fish consumption, and the 10-year risk of fatal and nonfatal coronary heart disease in a large population of Dutch adults with low fish intake;de Goede;J Nutr,2010

3. A meta-analysis of randomized controlled trials and prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and coronary heart disease risk;Alexander;Mayo Clin Proc,2017

4. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis;Rizos;JAMA,2012

5. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis;Yokoyama;Lancet,2007

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide association study of therapeutic response to statin drugs in cardiovascular disease;Scientific Reports;2024-08-03

2. Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT;European Heart Journal - Cardiovascular Pharmacotherapy;2024-04-27

3. A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty Acids;Cardiovascular Drugs and Therapy;2024-02-16

4. Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins;Frontiers in Cardiovascular Medicine;2024-01-15

5. Omega-3 fatty acids for cardiovascular event lowering;European Journal of Preventive Cardiology;2024-01-03